Catalent Inc

CTLT

New York Stock Exchange. Currency in USD

44.68 -0.86 ( -1.89% )

Real time prices: December 09

Market Cap.
8.04B
Beta (5Y monthly)
1.23
Price/Earnings
15.05
EPS (TTM)
3.47
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
3.01M
1y Target Est.
73.38
Day's Range
44.41
-
47.16
52 Week's Range
40.69
-
130.97

Historical Summary

Performance
EPS growth
Share Buybacks

About Catalent Inc

Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Website
https://www.catalent.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
171.19M
Employees
19000
Address
14 Schoolhouse Road, Somerset, NJ, United States, 08873
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics, and cell and gene therapies in clinical trials. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply services. It serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was incorporated in 2007 and is headquartered in Somerset, New Jersey.

Latest news

Why Is Jazz (JAZZ) Up 0.1% Since Last Earnings Report?
Why Is Jazz (JAZZ) Up 0.1% Since Last Earnings Report?

Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a...
By Zacks Investment Research - 13 hours ago

Why Is Theravance Bio (TBPH) Up 1.6% Since Last Earnings Report?
Why Is Theravance Bio (TBPH) Up 1.6% Since Last Earnings Report?

Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take...
By Zacks Investment Research - 2 days ago

Catalent (CTLT) Expands Facility Capabilities in Shanghai
Catalent (CTLT) Expands Facility Capabilities in Shanghai

Catalent's (CTLT) latest capability expansion is expected to boost its business in the clinical trials...
By Zacks Investment Research - 3 days ago

Wall Street Breakfast: What Moved Markets
Wall Street Breakfast: What Moved Markets

Listen on the go! A daily podcast of Wall Street Breakfast will be available this...
By Seeking Alpha - 6 days ago

Why Is United Therapeutics (UTHR) Up 3.8% Since Last Earnings Report?
Why Is United Therapeutics (UTHR) Up 3.8% Since Last Earnings Report?

United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take...
By Zacks Investment Research - 1 week ago

Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Smart Beta ETF report for PBE
By Zacks Investment Research - 1 week ago

CarParts and Catalent have been highlighted as Zacks Bull and Bear of the Day
CarParts and Catalent have been highlighted as Zacks Bull and Bear of the Day

CarParts and Catalent have been highlighted as Zacks Bull and Bear of the Day.
By Zacks Investment Research - 3 weeks ago